Gilead Sciences Inc (GILD)

Total asset turnover

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Revenue (ttm) US$ in thousands 26,229,000 26,516,000 26,520,000 26,161,000 26,413,000 26,256,000 26,613,000 26,496,000 26,325,000 26,743,000 26,144,000 25,341,000 24,689,000 23,147,000 22,174,000 22,716,000 22,449,000 22,365,000 22,357,000 22,320,000
Total assets US$ in thousands 62,125,000 62,373,000 62,337,000 61,876,000 63,171,000 62,557,000 62,870,000 63,080,000 67,952,000 67,098,000 67,984,000 67,492,000 68,407,000 60,878,000 55,934,000 59,741,000 61,627,000 59,146,000 63,210,000 62,837,000
Total asset turnover 0.42 0.43 0.43 0.42 0.42 0.42 0.42 0.42 0.39 0.40 0.38 0.38 0.36 0.38 0.40 0.38 0.36 0.38 0.35 0.36

December 31, 2023 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $26,229,000K ÷ $62,125,000K
= 0.42

The total asset turnover ratio for Gilead Sciences, Inc. has remained fairly consistent over the past eight quarters, hovering around 0.44. This ratio indicates that Gilead Sciences generates approximately $0.44 in revenue for every $1 of total assets it holds. A stable total asset turnover ratio suggests that the company is effectively utilizing its assets to generate sales. It is important to note that while the total asset turnover ratio provides insights into the company's asset management efficiency, it should be analyzed in conjunction with other financial ratios and qualitative factors to gain a holistic view of Gilead Sciences' performance and financial health.


Peer comparison

Dec 31, 2023


See also:

Gilead Sciences Inc Total Asset Turnover (Quarterly Data)